Download Supplement
Propelling R&D for Novel Retinal Therapies Through Innovative Clinical Trial DesignByPeter K. Kaiser, MD,Jeffrey Heier, MD,Nadia K. Waheed, MD, MPHJuly 28th 2025
Could targeting retinal non-perfusion be the key to achieving true disease modification in diabetic retinopathy?July 17th 2025
Real World insights with EYLEA 8mgByDr Peter Kaiser, Cole Eye Institute, Cleveland Clinic, USAJuly 14th 2025